| Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo FJ Najm, M Madhavan, A Zaremba, E Shick, RT Karl, DC Factor, TE Miller, ... Nature 522 (7555), 216-220, 2015 | 448 | 2015 |
| Induction of myelinating oligodendrocytes in human cortical spheroids M Madhavan, ZS Nevin, HE Shick, E Garrison, C Clarkson-Paredes, ... Nature methods 15 (9), 700-706, 2018 | 304 | 2018 |
| Accumulation of 8, 9-unsaturated sterols drives oligodendrocyte formation and remyelination Z Hubler, D Allimuthu, I Bederman, MS Elitt, M Madhavan, KC Allan, ... Nature 560 (7718), 372-376, 2018 | 212 | 2018 |
| A reference human induced pluripotent stem cell line for large-scale collaborative studies CB Pantazis, A Yang, E Lara, JA McDonough, C Blauwendraat, L Peng, ... Cell stem cell 29 (12), 1685-1702. e22, 2022 | 137 | 2022 |
| Modeling the mutational and phenotypic landscapes of Pelizaeus-Merzbacher disease with human iPSC-derived oligodendrocytes ZS Nevin, DC Factor, RT Karl, P Douvaras, J Laukka, MS Windrem, ... The American Journal of Human Genetics 100 (4), 617-634, 2017 | 68 | 2017 |
| Suppression of proteolipid protein rescues Pelizaeus–Merzbacher disease MS Elitt, L Barbar, HE Shick, BE Powers, Y Maeno-Hikichi, M Madhavan, ... Nature 585 (7825), 397-403, 2020 | 59 | 2020 |
| Cell type-specific intralocus interactions reveal oligodendrocyte mechanisms in MS DC Factor, AM Barbeau, KC Allan, LR Hu, M Madhavan, AT Hoang, ... Cell 181 (2), 382-395. e21, 2020 | 47 | 2020 |
| Chemical screening identifies enhancers of mutant oligodendrocyte survival and unmasks a distinct pathological phase in Pelizaeus-Merzbacher disease MS Elitt, HE Shick, M Madhavan, KC Allan, BLL Clayton, C Weng, ... Stem Cell Reports 11 (3), 711-726, 2018 | 40 | 2018 |
| Advances and challenges in modeling inherited peripheral neuropathies using iPSCs J Van Lent, R Prior, G Pérez Siles, AN Cutrupi, ML Kennerson, ... Experimental & Molecular Medicine, 1-17, 2024 | 5 | 2024 |
| Disorders of myelin BLL Clayton, KC Allan, ZS Nevin, MS Elitt, PJ Tesar Neurodevelopmental Disorders, 309-335, 2020 | 2 | 2020 |
| Immunocytochemistry of motor neurons derived from iPSCs with the hNIL construct protocol M Sckaff, C Feliciano, Z Nevin, B Conklin, C Clelland | 1 | 2022 |
| Induction of myelinating oligodendrocytes in human cortical spheroids P Tesar, M Madhavan, Z Nevin | 1 | 2019 |
| Therapeutic suppression of proteolipid protein rescues Pelizaeus-Merzbacher Disease in mice MS Elitt, L Barbar, HE Shick, BE Powers, Y Maeno-Hikichi, M Madhavan, ... bioRxiv, 508192, 2018 | 1 | 2018 |
| ALLELE SPECIFIC EDITING TO TREAT FUS-INDUCED NEURODEGENERATION B Conklin, Z Nevin, M Sun, M Matia, H Watry US Patent App. 18/699,038, 2025 | | 2025 |
| Robust Workflows for the Expansion and Differentiation of Human Pluripotent Stem Cells as Aggregates in Suspension Culture EJP Nazareth, S McManus, Z Nevin, J Gill, D Kondro, L Lin, MA Walasek, ... TISSUE ENGINEERING PART A 29 (13-14), 2023 | | 2023 |
| ALLELE-SPECIFIC INACTIVATION OF DOMINANT NEGATIVE FUS MUTATIONS Z Nevin, M Matia, B Conklin JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 27, S99-S100, 2022 | | 2022 |
| A unifying mechanism for many small molecule enhancers of oligodendrocyte formation Z Hubler, D Allimuthu, I Bederman, MS Elitt, M Madhavan, KC Allan, ... JOURNAL OF NEUROCHEMISTRY 150, 230-230, 2019 | | 2019 |
| Modeling Genetic Diseases of Myelin Using Patient-derived Induced Pluripotent Stem Cells ZS Nevin Case Western Reserve University, 2017 | | 2017 |
| Leveraging pluripotent stem cells as a scalable platform to discover chemical therapeutics for genetic disorders of myelin MS Elitt, M Madhavan, E Shick, A Lager, Z Nevin, DJ Adams, PJ Tesar HUMAN GENE THERAPY 27 (11), A29-A29, 2016 | | 2016 |
| Drug-Based Modulation of Endogenous Stem Cells Promotes Functional Remyelination In Vivo A Zaremba, E Shick, RT Karl, DC Factor, TE Miller, ZS Nevin, C Kantor, ... SHORT COURSE I, 51, 2015 | | 2015 |